• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    New Sensodyne Clinical Repair Toothpaste Launches with Breakthrough Formula for Rapid, Clinically Proven Sensitivity Relief

    2/10/26 10:01:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $HLN alert in real time by email

    The breakthrough formula starts to repair sensitive areas of teeth after 60 seconds for substantial sensitivity relief in 3 days, delivering long-lasting relief with twice-daily brushing

    Key Takeaways

    • Sensodyne unveils Clinical Repair, the brand's newest toothpaste option for sensitive teeth.
    • Clinical Repair:
      • Starts to repair sensitive areas of teeth after 60 seconds* for clinically proven long-lasting relief**.
      • With twice daily brushing, Clinical Repair generates a protective layer that restrengthens with every use – protecting against sensitivity returning**
      • Designed to target and strengthen enamel, addressing sensitivity at the source.
    • Developed with a science-backed formula that delivers clinical efficacy with a clean, refreshing feel and an enjoyably minty brushing experience across two options:
      • Whiten & Shine: A cool, arctic mint blend of peppermint and spearmint
      • Fresh Clean: Rich, refreshing mix of peppermint and eucalyptus

    The No. 1 dentist-recommended brand for sensitive teeth has launched Sensodyne Clinical Repair, its newest option for sensitive teeth, a toothpaste designed to address the root cause of tooth sensitivity. Based on data showing that 85% of people with sensitive teeth want solutions that repair sensitivity by addressing the root cause of their pain, Sensodyne developed Clinical Repair to go beyond temporary relief and actively repair sensitive areas of teeth with continued use.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210680667/en/

    Tooth sensitivity affects millions of adults and can make everyday moments – from enjoying hot drinks to savoring cold treats – uncomfortable or painful. Powered by a scientifically backed formula, Sensodyne Clinical Repair starts to repair sensitive areas of teeth after 60 seconds*, forming a protective layer that restrengthens with every use to deliver clinically proven, long-lasting relief from sensitivity.

    "Oral care is a daily essential in any personal care routine, yet for those with vulnerable, sensitive teeth, even simple moments can feel uncomfortable, from sipping a hot coffee in the morning to smiling with confidence," said Rishi Mulgund, Senior Director of Sensodyne in the US. "People with sensitive teeth aren't looking for short-term fixes. They want care they can trust to help protect sensitive teeth at the source, which is why we created Sensodyne Clinical Repair."

    Innovative Repair Technology, Backed by Science

    Sensodyne Clinical Repair features a formula that stays stable until brushing begins, when it's activated by saliva. Once activated, it forms a protective layer over sensitive areas of teeth. With twice-daily brushing, this layer restrengthens with every use, protecting against sensitivity returning, all without changing your everyday brushing routine.

    In clinical studies, Sensodyne Clinical Repair created a protective layer that was harder and offered more complete coverage than two leading competitors, raising the bar in sensitivity repair.

    Two Options Designed for Everyday Oral Care Needs

    Sensodyne Clinical Repair is designed to fit seamlessly into daily routines, helping people protect sensitive teeth while delivering cleaning and whitening benefits. The toothpaste is available in two refreshing options, now in a new blue color:

    • Sensodyne Clinical Repair Whiten & Shine: Formulated for people who want sensitivity relief and a brighter smile. Whiten & Shine provides repair-focused sensitivity relief alongside superior whitening from stain removal. A cool, arctic mint blend of peppermint and spearmint leaves the mouth feeling fresh and polished.
    • Sensodyne Clinical Repair Fresh Clean: Designed for those who want a deep clean and long-lasting freshness. Fresh Clean delivers gentle, repair-focused sensitivity relief with cleaning action through stain removal, featuring a rich, foaming formula and a refreshing blend of peppermint and eucalyptus for a just-brushed feeling that lasts.

    Built for Modern Routines

    As personal care routines become more intentional and performance-driven, Sensodyne Clinical Repair is designed to fit seamlessly into everyday brushing, delivering fast, reliable protection without compromise. Its clinically proven repair technology provides substantial sensitivity relief in as little as three days**, while continuing to strengthen protection with ongoing use.

    Pricing & Availability

    Sensodyne Clinical Repair is now available at leading retailers, such as Amazon, Walmart, and Target, and nationwide soon, with an MSRP of $8.99.

    For more information about Sensodyne Clinical Repair, visit www.sensodyne.com.

    * for substantial sensitivity relief in three days

    ** with twice-daily brushing

    ** with continued twice daily brushing

    About Sensodyne

    Sensodyne is the No. 1 dentist-recommended brand for sensitive teeth and has been trusted by consumers worldwide for decades. With a commitment to science-backed innovation, Sensodyne continues to advance oral health solutions designed to help people live more comfortably, every day.

    About Haleon US

    Haleon (NYSE:HLN) is a leading global consumer health company with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories: Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health. Built on trusted science, innovation, and deep human understanding, Haleon's U.S. brands include Abreva, Advil, Benefiber, Centrum, Emergen-C, Excedrin, Flonase, Gas-X, Nexium, Nicorette, Parodontax, Polident, Preparation H, Pronamel, Sensodyne, Robitussin, Theraflu, TUMS, Voltaren, and more. For more information on Haleon and its brands, please visit www.haleon.com or contact [email protected].

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260210680667/en/

    MEDIA CONTACTS



    Susana Pastrana

    [email protected]

    Get the next $HLN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLN

    DatePrice TargetRatingAnalyst
    1/23/2026Equal Weight → Overweight
    Barclays
    9/16/2025Overweight → Equal Weight
    Barclays
    9/10/2025Neutral → Buy
    Goldman
    5/27/2025$13.40Neutral → Outperform
    BNP Paribas Exane
    5/9/2025$11.25Equal-Weight → Overweight
    Morgan Stanley
    3/5/2025Buy → Hold
    HSBC Securities
    1/10/2025Overweight → Equal-Weight
    Morgan Stanley
    1/8/2025Outperform → Mkt Perform
    Bernstein
    More analyst ratings

    $HLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    New Sensodyne Clinical Repair Toothpaste Launches with Breakthrough Formula for Rapid, Clinically Proven Sensitivity Relief

    The breakthrough formula starts to repair sensitive areas of teeth after 60 seconds for substantial sensitivity relief in 3 days, delivering long-lasting relief with twice-daily brushing Key Takeaways Sensodyne unveils Clinical Repair, the brand's newest toothpaste option for sensitive teeth. Clinical Repair: Starts to repair sensitive areas of teeth after 60 seconds* for clinically proven long-lasting relief**. With twice daily brushing, Clinical Repair generates a protective layer that restrengthens with every use – protecting against sensitivity returning** Designed to target and strengthen enamel, addressing sensitivity at the source. Developed with a science-backe

    2/10/26 10:01:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    TUMS Unveils Sweepstakes and Limited-Edition Burn Ball to Help Fans "Pass the TUMS" Ahead of Football's Big Game

    Viral mega-creator Airrack joins the brand for a playful campaign featuring trick shots, social sweepstakes and heartburn relief that's passable WARREN, N.J., Jan. 6, 2026 /PRNewswire/ -- One in four Big Game watchers experience occasional heartburn from their favorite foods — and 75% of those fans are unprepared, without relief on hand*. This year, ahead of football's biggest showdown, TUMS is debuting the first-ever Burn Ball — a limited-edition, custom-designed football, specifically engineered to pass the TUMS and deliver fast-acting heartburn relief on game day! The most

    1/6/26 9:18:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Glasgow Caledonian University to Lead £2.6m UK Doctoral Training Programme to Tackle Global Oral Health Challenges

    Glasgow Caledonian University has secured £2.6 million to lead a major new UK-wide doctoral training programme to spearhead research into oral health and dental disease prevention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216404233/en/ Funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and delivered in partnership with Haleon, a consumer company focused on better everyday health, the six-year initiative will support 20 PhD students across five universities. Students will investigate some of the biggest challenges in oral health, including gum disease, and tooth decay and sensitivity, and will w

    12/16/25 8:54:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    $HLN
    SEC Filings

    View All

    SEC Form 6-K filed by Haleon plc

    6-K - Haleon plc (0001900304) (Filer)

    2/12/26 6:50:21 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by Haleon plc

    SCHEDULE 13G/A - Haleon plc (0001900304) (Subject)

    2/10/26 11:23:20 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 6-K filed by Haleon plc

    6-K - Haleon plc (0001900304) (Filer)

    2/2/26 1:54:38 PM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    $HLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Haleon plc upgraded by Barclays

    Barclays upgraded Haleon plc from Equal Weight to Overweight

    1/23/26 8:10:24 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Haleon plc downgraded by Barclays

    Barclays downgraded Haleon plc from Overweight to Equal Weight

    9/16/25 8:03:47 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Haleon plc upgraded by Goldman

    Goldman upgraded Haleon plc from Neutral to Buy

    9/10/25 7:56:26 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    $HLN
    Leadership Updates

    Live Leadership Updates

    View All

    HALEON APPOINTS CARL HANEY AS CHIEF R&D OFFICER

    LONDON, June 24, 2025 /PRNewswire/ -- Haleon (LSE: HLN) (NYSE:HLN) today announces the appointment of Carl Haney as Chief Research & Development Officer. Carl will join Haleon on 1 August 2025.  This appointment follows Franck Riot deciding to leave Haleon after six years in the business.  Carl joins Haleon from the Estée Lauder Companies Inc. where he has spent 13 years as Executive Vice President, Global Innovation and Research and Development. Carl previously spent over 20 years at P&G across Home, Health and Beauty Care.  Brian McNamara, Haleon's Chief Executive Officer commented: "I am delighted to welcome Carl to Haleon. Carl is a world-renowned leader in R&D, with significant experi

    6/24/25 8:00:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Haleon Welcomes Joe Sta-Romana as Chief Customer Officer to Lead US Growth and Transformation

    WARREN, N.J., Dec. 2, 2024 /PRNewswire/ -- Haleon, a world-leading consumer health company, is pleased to announce the appointment of Joe Sta-Romana as Chief Customer Officer (CCO) for its US business, effective December 1, 2024.  In this role, Joe will lead the organization's customer strategy, driving growth and transformation in the US market. Joe brings extensive leadership experience to the role, having spent over 20 years in the FMCG sector and serving in the military. Most recently Joe led Unilever's Walmart business, overseeing the company's largest US customer. In his

    12/2/24 7:53:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    $HLN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Haleon plc

    SC 13G - Haleon plc (0001900304) (Subject)

    11/13/24 1:20:28 PM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Haleon plc

    SC 13D/A - Haleon plc (0001900304) (Subject)

    10/3/24 6:59:16 PM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Haleon plc

    SC 13D/A - Haleon plc (0001900304) (Subject)

    10/1/24 7:38:46 PM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    $HLN
    Financials

    Live finance-specific insights

    View All

    Yellow Wood Partners Portfolio Company Suave Brands Company Completes ChapStick Acquisition

    BOSTON, June 3, 2024 /PRNewswire/ -- Yellow Wood Partners LLC ("Yellow Wood"), a Boston-based private equity firm known for investing in consumer brands and companies, is pleased to announce that its portfolio company, Suave Brands Company, has successfully completed the acquisition of the ChapStick brand from Haleon (NYSE:HLN). This transaction also results in Haleon becoming a shareholder in Suave Brands Company. Suave Brands Company Chief Executive Officer, Daniel Alter, said, "As we continue to build Suave Brands Company as the top independent North American beauty & personal care company by combining the agility of a start-up with the power of market leading brands, the addition of Cha

    6/3/24 7:00:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Yellow Wood Partners Portfolio Company Suave Brands Company Acquires ChapStick from Haleon

    BOSTON, Jan. 25, 2024 /PRNewswire/ -- Yellow Wood Partners ("Yellow Wood"), a Boston-based private equity firm focused on investing in consumer brands and companies, today announced that its portfolio company Suave Brands Company has signed a binding offer to acquire the ChapStick brand from Haleon (NYSE:HLN), a global leader in consumer health. The transaction is intended to close in the first half of 2024 upon completion of customary closing and regulatory approvals. ChapStick invented the lip care category in the 1880s with the launch of a now-iconic lip balm that made ChapStick a household name. For more than a century, ChapStick has added products to its portfolio with innovative new i

    1/25/24 2:05:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Haleon plc Announces Expiration and Results of Exchange Offers for Certain Series of Notes Issued in Private Placements in Connection with the Separation from GSK

    Not for release, publication or distribution, directly or indirectly, in or into any jurisdiction into which such distribution would be unlawful. This notice is for informational purposes only and does not constitute an offer to purchase, or a solicitation of an offer to sell, any securities. The exchange offers referred to herein are being made solely pursuant to the Prospectus and related documents. The exchange offers referred to herein are not being made to holders of securities in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. LONDON, Oct. 31, 2022 /PRNewswire/ -- Haleon plc ("Haleon

    10/31/22 10:20:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary